Procollagen type 1 amino-terminal propeptide (P1NP) and risk of hip fractures in elderly Norwegian men and women. A NOREPOS study

Bone. 2014 Jul:64:1-7. doi: 10.1016/j.bone.2014.03.010. Epub 2014 Mar 22.

Abstract

The current study aimed to assess a possible association between the bone turnover marker procollagen type 1 amino-terminal propeptide (P1NP) and future hip fractures in elderly Norwegian men and women and to elucidate the relation between P1NP, bone mineral density and 25-hydroxyvitamin D (25(OH)D). Men and women aged 71 to 77 from two population based health studies in Norway (1999-2001) were followed for a median period of 7.3 years with respect to hip fractures. The study was designed as a case-cohort study. P1NP and 25(OH)D were analysed in frozen serum samples obtained at baseline in hip fracture patients (n=340) and in randomly selected sex stratified sub-cohorts. Bone mineral density was measured by dual-energy X-ray absorptiometry (DXA) in a subset of participants. Cox proportional hazards regression with inverse probability weighting and robust variance was performed. No significant correlation between 25(OH)D and P1NP was found. A negative correlation between P1NP and BMD was observed in women (Rho=-0.36, p=0.001). A similar trend was observed in men. No association between quartiles of P1NP and rate of subsequent hip fractures was found. Spline analyses suggested a higher rate of hip fracture at P1NP levels above 60 μg/L in both men and women. A higher hip fracture rate, which was independent of BMD, was also indicated in women with very low levels of P1NP.

Keywords: Bone turnover marker; Elderly; Hip fractures; Osteoporosis; Procollagen type 1 amino-terminal propeptide.

MeSH terms

  • Aged
  • Cohort Studies
  • Female
  • Hip Fractures / blood
  • Hip Fractures / epidemiology*
  • Humans
  • Male
  • Norway / epidemiology
  • Peptide Fragments / blood*
  • Procollagen / blood*
  • Proportional Hazards Models
  • Risk Factors

Substances

  • Peptide Fragments
  • Procollagen
  • procollagen Type I N-terminal peptide